Genericart Metoprolol Succinate 25mg Tablet ER
Images are for reference. Actual packaging may vary.
Metoprolol Succinate (23.75mg)
1 units • Other
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Medical applications
Genericart Metoprolol Succinate 25mg Tablet ER contains Metoprolol Succinate 23.75mg, an extended-release beta-1 selective adrenergic receptor blocker indicated for the management of hypertension, angina pectoris, and heart failure. By selectively inhibiting beta-1 receptors in the heart, it reduces heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure and decreasing myocardial oxygen demand.
This extended-release formulation ensures a gradual and sustained release of the active ingredient, promoting stable plasma concentrations and enhancing patient compliance through once-daily dosing. Genericart Metoprolol Succinate is also utilized post-myocardial infarction to improve survival by reducing cardiac workload and preventing arrhythmias. It is contraindicated in patients with severe bradycardia, cardiogenic shock, or overt cardiac failure requiring intravenous inotropic therapy.
Caution is advised in patients with bronchospastic diseases, diabetes mellitus, and peripheral vascular disorders. Common adverse effects include fatigue, dizziness, hypotension, and gastrointestinal disturbances. Dose adjustments may be necessary in renal or hepatic impairment. Patients should be advised not to discontinue therapy abruptly to avoid exacerbation of angina or precipitating myocardial infarction.
Regular monitoring of blood pressure, heart rate, and clinical status is recommended to optimize therapeutic outcomes and minimize adverse effects.
Alcohol & phenols
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Genericart Metoprolol Succinate 25mg Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Genericart Metoprolol Succinate 25mg Tablet ER is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Genericart Metoprolol Succinate 25mg Tablet ER is safe to use in patients with kidney disease. No dose adjustment of Genericart Metoprolol Succinate 25mg Tablet ER is recommended.
Exercise Caution
Genericart Metoprolol Succinate 25mg Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Genericart Metoprolol Succinate 25mg Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Genericart Metoprolol Succinate 25mg Tablet ER may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Genericart Metoprolol Succinate 25mg Tablet ER






